Apriss announces successful test run of MethCheck electronic logbook
LOUISVILLE, Ky. Coming fresh off a successful pilot test in Kentucky, Apriss is currently showcasing its MethCheck electronic clearing house—a system that satisfies logbook requirements on the purchase of pseudoephedrine products and captures that data for local law enforcement in their efforts to combat methamphetamine crimes in the area.
Because the purchase and verification are both electronically recorded, the MethCheck system both eliminates any paper logbook storage requirements for the retailer and provides a real-time tool to law enforcement to help identify consumers who may be buying PSE products to feed a meth lab in place of combating a cold or allergies. “Because it’s real time, we can also block sales if the state law directs the pharmacies to do so,” commented Jim Acquisto, director of MethCheck for Apriss. “Which is what we do in Kentucky. We actually recommend that a transaction be denied if it exceeds state or federal law.”
And while the system eliminates costs associated with paper logbooks of PSE transactions, the cost to implement the system may only be the time it takes to train store employees on its use. For the Kentucky pilot, the state is picking up the tab both in getting the system up and running in every retailer authorized to sell PSE products and maintaining that data warehouse.
For those states not supplementing the cost of the system, the savings in labor costs managing a paper log system more than funds the cost of the MethCheck system, commented John Mahoney, Apriss director of business development.
AHIMA applauds Barack Obama for campaign success
CHICAGO The American Health Information Management Association has congratulated Barack Obama on his election as president of the United States, calling for reform of the healthcare system.
“Given the president-elect’s strong statements in support of health information as a key to expanding healthcare coverage while improving quality and controlling costs‹most recently during his infomercial last week—AHIMA is understandably optimistic,” AHIMA chief executive officer Linda Kloss said in a statement. “We urge the Obama administration to pursue the imperative of a 21st century health information platform that offers providers, payers and patients the accurate, integrated and secure electronic information they need to make decisions of utmost importance.”
GlaxoSmithKline consolidates U.S. headquarters, announces layoffs of 1,000
PHILADELPHIA GlaxoSmithKline, the maker of Abreva, Aquafresh toothpastes, Nicorette, Sensodyne and Tums will cut its workforce by about 1,800 jobs and make Research Triangle Park in North Carolina its permanent North American headquarters, replacing the current U.S. headquarters in Philadelphia, reports said today.
GlaxoSmithKline has had duel headquarters in the United States since the merger between Glaxo Wellcome and SmithKline Beecham was finalized in 2000, The Wall Street Journal today reported.
Today, GSK said that it will cut 1,800 positions, laying off about 1,000 people and eliminating hundreds of vacant positions, reports said.
GSK’s global headquarters are in London. The company is currently in the midst of belt-tightening in many departments due to growing pressure from the quickly expanding generic drug market and a decline in drug sales.